Patient info Open main menu

Fulvestrant Fresenius Kabi 250 mg solution for injection in Pre-filled syringe – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: Prescription only (POM) Details

Medicine strength:
250 mg (50 mg/ml)
Contains active substance:
ATC code:
Similar medicines:

Summary of Product Characteristics (SmPC) - Fulvestrant Fresenius Kabi 250 mg solution for injection in Pre-filled syringe

Sources: Original (products.mhra.gov.uk)

Facts about Fulvestrant Fresenius Kabi 250 mg solution for injection in Pre-filled syringe

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Fulvestrant
Strength 250 mg (50 mg/ml)
Pharmaceutical form Solution for injection
How is it taken Intramuscular
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L02 Endocrine therapy antineoplastic and immunomodulating agents
      1. L02B Hormone antagonists and related agents
        1. L02BA Anti-estrogens
          1. L02BA03 fulvestrant
Codes BNF 08030401

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.